Live feed20:20:00·671dPRReleasevia QuantisnowAdaptimmune Receives U.S. FDA Accelerated Approval of TECELRA® (afamitresgene autoleucel), the First Approved Engineered Cell Therapy for a Solid TumorByQuantisnow·Wall Street's wire, on your screen.ADAP· Adaptimmune Therapeutics plcHealth Care
